Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up…

Douglas A. McIntyre | Dec 5, 2007 at 8:42 AM EST

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced that dosing has commenced in its Phase IIa clinical trial with LX6171. This…

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Dec 4, 2007 at 7:44 AM EST

Medarex Spreads Its Wings (MEDX, BMY)

Medarex, Inc. (Nasdaq: MEDX) this morning has announced the allowance of two separate investigational new drug applications filed with the…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Nov 21, 2007 at 1:11 PM EST

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

Bronchus Technologies, Inc. filed yesterday for an initial public offering of up to $86.25 million for filing purposes. It has…

Douglas A. McIntyre | Nov 21, 2007 at 12:55 PM EST

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Aegerion Pharmaceuticals, Inc. filed Tuesday for an initial public offering of up to $86.25 million in securities for filing purposes. …

Douglas A. McIntyre | Nov 20, 2007 at 3:48 PM EST

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Pfizer (NYSE:PFE) is seeing additional pressure this afternoon. Apparently the FDA said it is looking into reports that Pfizer has…

Douglas A. McIntyre | Nov 20, 2007 at 9:23 AM EST

Quality Systems Free From SEC Inquiry (QSII)

Quality Systems, Inc. (NASDAQ:QSII) has issued a release stating that it received a letter dated November 19, 2007, from the…

Douglas A. McIntyre | Nov 15, 2007 at 3:04 PM EST

GlaxoSmithKline (GSK) Take More Heat

Now that the FDA has forced GlaxoSmithKline (GSK) to put a "black label" on its diabetes drug Avandia, the competition…

Douglas A. McIntyre | Nov 13, 2007 at 4:03 PM EST

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Affymetrix (NASDAQ:AFFX) was a bit of a puzzling stock today when we saw it had hit a 52-week low after…

Douglas A. McIntyre | Nov 12, 2007 at 1:54 PM EST

Glaxo (GSK) CEO Has A Senior Moment

GlaxoSmithKline’s (GSK) diabetes drug Avandia has such frightening side effects that the FDA will probably make it carry a "black…

Douglas A. McIntyre | Nov 12, 2007 at 6:45 AM EST

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue…

Douglas A. McIntyre | Nov 9, 2007 at 6:13 AM EST

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems…

Douglas A. McIntyre | Nov 8, 2007 at 4:57 PM EST

Allscripts… Just When You Thought It Was Safe (MDRX)

Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) is trading at a new 52-week low after a disaster earnings report this afternoon. Non-GAAP…

1 … 360 361 362 363 364 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Medarex Spreads Its Wings (MEDX, BMY)

Abbott’s (ABT) Hammers Boston Scientific (BSX)

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Quality Systems Free From SEC Inquiry (QSII)

GlaxoSmithKline (GSK) Take More Heat

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Glaxo (GSK) CEO Has A Senior Moment

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

Allscripts… Just When You Thought It Was Safe (MDRX)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Medarex Spreads Its Wings (MEDX, BMY)

Abbott’s (ABT) Hammers Boston Scientific (BSX)

IPO Filing Floodgates: Bronchus Technologies, Inc. (LUNG)

IPO Filing Floodgates: Aegerion Pharmaceuticals, Inc. (AEGR)

Does Big Tobacco Actually Love Pfizer’s Anti-Smoking ‘Chantix’ Pill? (MO, RAI, PFE)

Quality Systems Free From SEC Inquiry (QSII)

GlaxoSmithKline (GSK) Take More Heat

Affymetrix Year-Lows On Debt..No Good Deed Goes Unpunished (AFFX)

Glaxo (GSK) CEO Has A Senior Moment

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

Allscripts… Just When You Thought It Was Safe (MDRX)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%